Cancer research is being conducted all around the country, but in our own backyard discoveries related to the termination of prostate cancer cells are in the works.
Christopher McGoldrick, a doctoral candidate in East Tennessee State University’s Department of Biomedical Sciences at the James H. Quillen College of Medicine and graduate research assistant under the faculty supervision of Dr. William Stone, has been working since he was an undergraduate in 2007 to research a prodrug that would be used in chemotherapy to help treat prostate cancer.
McGoldrick said the initial approach to this project, “Identification of Oxidized Protein Hydrolase as a Prodrug Target in Prostate Cancer,” was to look for a universal treatment option.
Read the full story on the Johnson City Press website.